Tuesday February 9, 2010 2:41 PM ET
SmartMoney
Share Price ($): 
17.93
Price Change: 
0.09 (0.50%)
Last 10 Quotes
What is this?
PFE 
(Pfizer Inc.)
Exchange: NYSE     Industry: Drug Manufacturers/Major
This quote for PFE is in Real-TimeThis quote is in Real-Time.  Last Trade 2:41 PM ET 2/9/2010
Click Here Click Here
Volume:47,100,778
Day's Low:$17.65
52-wk Low:$11.62
Previous Close:$17.84
Dividend:$0.18
Market Cap:143,960,500
Avg Volume: 50,835,900
Day's High:$18.15
52-wk High:$20.36
Open Price:$17.87
Yield: 4.04%
P/E (Forward): 8.15
Chart for PFE
Breaking News
12:18 PM  2/9/2010   UPDATE: Ratiopharm Shortlist Expected Early Next Week - Sources
11:35 AM  2/9/2010   UPDATE: Biogen 4Q Profit Up 48%; Offers Bright 2010 Forecast
11:14 AM  2/9/2010   Ratiopharm Shortlist Expected Early Next Week - Sources
11:08 PM  2/7/2010   UPDATE: CIC: US Stock Holdings Valued At $9.63 Billion End-2009
5:43 PM  2/5/2010   Biogen Plans First Study For Earlier Use Of MS Drug Tysabri
4:19 PM  2/5/2010   NY Fed: JPMorgan's Dimon, Pfizer's Kindler Re-Elected To Board
9:13 AM  2/4/2010   Four Bidders Remain In Race For Merckle's Ratiopharm -Source
Stories & Blogs: Around the Web
2/9/2010  Republicans and Democrats will debate on TV, but little may come of it. (The Motley Fool)
2/9/2010  And where to look for other "black swans." (The Motley Fool)
2/9/2010  Avoid a few key mistakes, and you'll lose less money. (The Motley Fool)
2/9/2010  Discount cards for drugs help Pfizer track patients' use. (The Motley Fool)
2/9/2010  Go from good to great. (The Motley Fool)
2/9/2010  Do it yourself and know what you're getting. (The Motley Fool)
2/9/2010  Market-trouncing returns could be written in these five stars. (The Motley Fool)
2/9/2010  Cholesterol Drug Approved for People Without High Cholesterol (WSJ.com)
Earnings & Forecast
Most Recent Quarter ($)Same Quarter Last Year ($)% Change
EPS, Pro Forma 0.49 0.65 -24.62
EPS, GAAP 0.07 0.04 75.00
Consensus Estimate 0.49 0.60 -18.33
Trailing 12 MonthsYear-Earlier Period% Change
EPS, Pro Forma 2.02 2.02 0.00
EPS, GAAP 1.21 1.20 0.83
Consensus Estimate 1.91 NA NA
Key Statistics
PFEIndustry Average
P/E (TTM) 14.74 14.70
P/E (Forward) 8.15 12.60
PEG Ratio 4.43 1.45
Price/Sales 2.63 2.51
Beta 0.73 0.74
Advertisements
View Overview for: